Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for endothelin- receptor
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- Retinal ganglion cells treated with endothelian ET-1, ET-2 or ET-3
Most Relevant Literature
- Selective endothelin A receptor antagonism in patients with proteinuric chronic kidney disease.
- Recent developments in the management of resistant hypertension: focus on endothelin receptor antago…
- Inhibition of endothelin A receptor by a novel, selective receptor antagonist enhances morphine-indu…
- New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension: A Systematic Review and Meta-A…
- Population pharmacokinetics of the dual endothelin receptor antagonist aprocitentan in subjects with…
Most Relevant Clinical Trials
- Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma
- Endothelin Receptor Antagonism in Proteinuric Nephropathy
- Endothelin Receptor Function and Acute Stress
- Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction
- Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma
